• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆神经丝轻链与非痴呆老年人大脑认知能力下降有关。

Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults.

机构信息

Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, 37 Allées Jules Guesdes, 31000, Toulouse, France.

Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA.

出版信息

Sci Rep. 2021 Jun 28;11(1):13394. doi: 10.1038/s41598-021-91038-0.

DOI:10.1038/s41598-021-91038-0
PMID:34183688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8238930/
Abstract

Neurofilament light chain (NfL) has been associated with cognitive status in multiple neurodegenerative conditions. Studies about plasma NfL and cognitive decline in older adults are still limited. 504 older adults (median age 75 years) who expressed memory complaints were selected from the Multidomain Alzheimer's Preventive Trial (MAPT) and were classified as normal cognition (NC) or mild cognitive impairment (MCI). Cognitive functions were measured as mini mental state examination (MMSE) and composite cognitive score (CCS) over a 4-year period. Plasma NfL was measured at the first or the second year of the MAPT. Mixed-effects linear models were performed to evaluate cross-sectional and longitudinal associations. In the whole population, higher plasma NfL was cross-sectionally associated with lower cognitive functions (MMSE: β =  - 0.007, 95% CI [- 0.013, - 0.001]; CCS: β =  - 0.003, 95% CI [- 0.006, - 0.001]). In adults with MCI, but not NC, higher plasma NfL was associated with lower CCS at the cross-sectional level (β =  - 0.003, 95% CI [- 0.005, - 0.0002]). The upper quartile NfL group further demonstrated more over time decline in CCS (β =  - 0.07, 95% CI [- 0.12, - 0.01]) under the MCI status. Plasma NfL can be a promising biomarker of progressive cognition decline in older adults with MCI.

摘要

神经丝轻链(NfL)与多种神经退行性疾病的认知状态有关。关于老年人血浆 NfL 与认知能力下降的研究仍然有限。从多领域阿尔茨海默病预防试验(MAPT)中选择了 504 名表达记忆主诉的老年人(中位年龄 75 岁),并将其分类为正常认知(NC)或轻度认知障碍(MCI)。在 4 年的时间里,使用简易精神状态检查(MMSE)和综合认知评分(CCS)来测量认知功能。在 MAPT 的第一年或第二年测量血浆 NfL。采用混合效应线性模型评估横断面和纵向关联。在整个人群中,较高的血浆 NfL 与较低的认知功能呈横断面相关(MMSE:β= - 0.007,95%置信区间[-0.013,-0.001];CCS:β= - 0.003,95%置信区间[-0.006,-0.001])。在 MCI 成人中,但在 NC 成人中,较高的血浆 NfL 与横断面的 CCS 较低相关(β= - 0.003,95%置信区间[-0.005,-0.0002])。在上四分位数 NfL 组中,在 MCI 状态下,CCS 的下降幅度更大(β= - 0.07,95%置信区间[-0.12,-0.01])。在 MCI 的老年人中,血浆 NfL 可能是认知进行性下降的有前途的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d065/8238930/ad993b0f20d9/41598_2021_91038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d065/8238930/ad993b0f20d9/41598_2021_91038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d065/8238930/ad993b0f20d9/41598_2021_91038_Fig1_HTML.jpg

相似文献

1
Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults.血浆神经丝轻链与非痴呆老年人大脑认知能力下降有关。
Sci Rep. 2021 Jun 28;11(1):13394. doi: 10.1038/s41598-021-91038-0.
2
Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults.血浆 Aβ 和神经丝轻链与非痴呆老年患者认知和身体功能下降有关。
Alzheimers Res Ther. 2020 Oct 8;12(1):128. doi: 10.1186/s13195-020-00697-0.
3
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.基于血浆生物标志物预测轻度认知障碍患者的纵向认知下降和阿尔茨海默病转化。
Cells. 2024 Jun 22;13(13):1085. doi: 10.3390/cells13131085.
4
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.血浆神经丝轻链作为神经退行性疾病认知下降的预后标志物:一项临床研究。
Alzheimers Res Ther. 2024 Oct 19;16(1):231. doi: 10.1186/s13195-024-01593-7.
5
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
6
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study.血浆神经丝轻链可预测主观认知下降和轻度认知障碍患者的阿尔茨海默病:一项横断面和纵向研究。
Eur J Neurol. 2024 Jan;31(1):e16089. doi: 10.1111/ene.16089. Epub 2023 Oct 5.
7
Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study.阿尔茨海默病两种血浆生物标志物(神经丝轻链和寡聚态 Aβ)的随访比较:一项初步研究。
Curr Alzheimer Res. 2023;20(10):715-724. doi: 10.2174/0115672050284054240119101834.
8
Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.阿尔茨海默病或帕金森病患者血浆神经丝轻链水平与认知功能的关系。
Sci Rep. 2018 Nov 26;8(1):17368. doi: 10.1038/s41598-018-35766-w.
9
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.阿尔茨海默病及相关疾病的血浆生物标志物与认知和认知衰退的关联:基于人群的 MYHAT 研究。
Alzheimers Dement. 2024 Jun;20(6):4199-4211. doi: 10.1002/alz.13829. Epub 2024 May 16.
10
Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT Study.健康老年人的体力活动、神经退行性变的血液生物标志物与认知之间的关联:MAPT 研究。
J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1382-1390. doi: 10.1093/gerona/glab094.

引用本文的文献

1
Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men.血浆神经丝轻链反映出男性阿尔茨海默病更严重的表现。
Mol Psychiatry. 2025 Aug 12. doi: 10.1038/s41380-025-03149-z.
2
Evaluating the safety and feasibility of remote ischemic conditioning for slowing cognitive decline in mild Alzheimer's dementia.评估远程缺血预处理对减缓轻度阿尔茨海默病性痴呆认知衰退的安全性和可行性。
Front Neurol. 2025 Jun 24;16:1592829. doi: 10.3389/fneur.2025.1592829. eCollection 2025.
3
Plasma proteomics for cognitive decline and dementia-A Southeast Asian cohort study.

本文引用的文献

1
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.基于血浆生物标志物组合对轻度认知障碍认知能力下降和痴呆的个体化预后评估。
Nat Aging. 2021 Jan;1(1):114-123. doi: 10.1038/s43587-020-00003-5. Epub 2020 Nov 30.
2
Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population.基于血液的生物标志物用于巴基斯坦人群认知障碍的预测性诊断
Front Aging Neurosci. 2020 Jul 22;12:223. doi: 10.3389/fnagi.2020.00223. eCollection 2020.
3
The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
血浆蛋白质组学与认知衰退和痴呆——一项东南亚队列研究
Alzheimers Dement. 2025 Feb;21(2):e14577. doi: 10.1002/alz.14577.
4
Plasma homocysteine level and trajectories in association with longitudinal increase in plasma neurofilament light among urban adults.城市成年人血浆同型半胱氨酸水平及轨迹与血浆神经丝轻链纵向增加的关系
Geroscience. 2025 Feb 19. doi: 10.1007/s11357-025-01567-z.
5
Biofluid biomarkers for Alzheimer's disease: past, present, and future.用于阿尔茨海默病的生物流体生物标志物:过去、现在和未来。
Med Rev (2021). 2024 Oct 17;4(6):467-491. doi: 10.1515/mr-2023-0071. eCollection 2024 Dec.
6
Association of frailty and serum neurofilament light chain levels: the mediating role of estimated glomerular filtration rate.衰弱与血清神经丝轻链水平的关联:估算肾小球滤过率的中介作用
Front Aging Neurosci. 2024 Oct 11;16:1475505. doi: 10.3389/fnagi.2024.1475505. eCollection 2024.
7
Emerging Trends: Neurofilament Biomarkers in Precision Neurology.新兴趋势:精准神经医学中的神经丝生物标志物。
Neurochem Res. 2024 Dec;49(12):3208-3225. doi: 10.1007/s11064-024-04244-3. Epub 2024 Sep 30.
8
Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging.健康老龄化中神经退行性变、潜在认知能力和身体活动的血浆标志物。
Sci Rep. 2024 Sep 17;14(1):21702. doi: 10.1038/s41598-024-72806-0.
9
Serum neurofilament light chain as a prognostic marker of all-cause mortality in a national sample of US adults.血清神经丝轻链作为美国成年人全因死亡率的预后标志物。
Eur J Epidemiol. 2024 Jul;39(7):795-809. doi: 10.1007/s10654-024-01131-7. Epub 2024 May 21.
10
Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men.社区中老年男性血浆神经丝轻链与认知和神经影像学测量的相关性。
Alzheimers Res Ther. 2024 Apr 25;16(1):90. doi: 10.1186/s13195-024-01464-1.
神经丝轻链在额颞叶痴呆中的作用:一项荟萃分析。
Aging Clin Exp Res. 2021 Apr;33(4):869-881. doi: 10.1007/s40520-020-01554-8. Epub 2020 Apr 18.
4
Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition.脑脊液和血浆神经丝轻链与认知异常有关。
Alzheimers Dement (Amst). 2019 Oct 22;11:700-709. doi: 10.1016/j.dadm.2019.08.008. eCollection 2019 Dec.
5
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.血浆和脑脊液神经丝轻链:与纵向神经影像学和认知测量的关系。
Neurology. 2019 Jul 16;93(3):e252-e260. doi: 10.1212/WNL.0000000000007767. Epub 2019 Jun 10.
6
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.脑脊髓液神经丝轻链蛋白水平与痴呆、运动神经元病和运动障碍患者认知的相关性。
JAMA Neurol. 2019 Mar 1;76(3):318-325. doi: 10.1001/jamaneurol.2018.3746.
7
Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.阿尔茨海默病或帕金森病患者血浆神经丝轻链水平与认知功能的关系。
Sci Rep. 2018 Nov 26;8(1):17368. doi: 10.1038/s41598-018-35766-w.
8
Neurofilaments as biomarkers in neurological disorders.神经丝作为神经紊乱的生物标志物。
Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z.
9
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.从脑脊液到血液:阿尔茨海默病的第三波体液生物标志物。
J Alzheimers Dis. 2018;64(s1):S271-S279. doi: 10.3233/JAD-179926.
10
Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.血浆神经丝轻链与认知正常老年参与者额皮质淀粉样-β负荷和认知表现的关系。
J Alzheimers Dis. 2018;63(2):479-487. doi: 10.3233/JAD-180025.